D.E. Shaw & Co
SMTI icon

D.E. Shaw & Co’s Sanara MedTech SMTI Stock Holding History

D.E. Shaw & Co’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$386K Buy
16,370
+47
+0.3% +$972 ﹤0.01% 4295
2026
Q1 		$280K Buy
16,323
+2,020
+14% +$41.6K ﹤0.01% 4104
2025
Q4 		$334K Buy
+14,303
New +$369K ﹤0.01% 4101

Other funds holding SMTI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

D.E. Shaw & Co's SMTI Position: Q2 2026 in Review

D.E. Shaw & Co increased its Sanara MedTech (SMTI) stake by 0.29% in Q2 2026, buying an estimated $972 and bringing the position to 16,370 shares worth $386K. The position accounts for ﹤0.01% of the portfolio, ranked #4295.

D.E. Shaw & Co first reported a position in SMTI in Q4 2025 and has held it in 3 quarters since. 75 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

  • D.E. Shaw & Co held 16,370 shares of Sanara MedTech worth $386K as of Q2 2026.
  • D.E. Shaw & Co bought 47 Sanara MedTech shares in Q2 2026, an estimated $972.
  • Sanara MedTech made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #4295 holding.
  • D.E. Shaw & Co first reported a position in Sanara MedTech in Q4 2025 and has held it in 3 quarters since.
  • 75 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.